Abbott Laboratories (Pakistan) Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abbott Laboratories (Pakistan) Ltd with three other
companies in this sector in PAKISTAN :
Searle Co Ltd
sales of 18.06 billion Pakistan Rupees [US$107.29 million]
of which 79%
Glaxosmithkline Consumer Healthcare Pakistan Ltd
(16.32 billion Pakistan Rupees [US$96.92 million]
of which 100%
was Consumer HealthCare), and
GlaxoSmithKline Pakistan Limited
(36.58 billion Pakistan Rupees [US$217.30 million]
During the year ended December of 2019, sales at
Abbott Laboratories (Pakistan) Ltd were 30.16 billion Pakistan Rupees (US$179.13 million).
a very small
increase of 1.5%
versus 2018, when the company's sales were 29.72 billion Pakistan Rupees .
This was the fifth consecutive year of sales increases at Abbott Laboratories (Pakistan) Ltd
(and since 2014, sales have increased a total of 53%).
Sales of Nutritional saw an increase
that was more than double the company's growth rate: sales were up
16.0% in 2019, from
5.35 billion Pakistan Rupees to 6.20 billion Pakistan Rupees .
Abbott Laboratories (Pakistan) Ltd also saw significant increases in sales in
Other (up 10.4% to 2.75 billion Pakistan Rupees )
Not all segments of Abbott Laboratories (Pakistan) Ltd experienced an increase in sales in 2019:
sales of Pharmaceutical fell 3.1% to 21.20 billion Pakistan Rupees .